HI
ALNA

Harbour Investments’s Allena Pharmaceuticals ALNA Stock Holding History

Harbour Investments’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,000
Closed -$5K – 3970
2021
Q3 		$5K Buy
6,000
+500
+9% +$490 ﹤0.01% 3044
2021
Q2 		$7K Buy
5,500
+2,500
+83% +$3.03K ﹤0.01% 2948
2021
Q1 		$4K Buy
+3,000
New +$5K ﹤0.01% 3038

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harbour Investments's ALNA Position: Q4 2021 in Review

Harbour Investments sold out of Allena Pharmaceuticals (ALNA) in Q4 2021, closing a stake of 6,000 shares — an estimated $5K sold.

Harbour Investments first reported a position in ALNA in Q1 2021 and held it in 3 quarters. The position peaked at $7K in Q2 2021. 30 funds tracked by Wall St. Rank hold ALNA as of Q4 2021.

  • Harbour Investments reported no remaining Allena Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 6,000 Allena Pharmaceuticals shares in Q4 2021, an estimated $5K.
  • Harbour Investments first reported a position in Allena Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Allena Pharmaceuticals position peaked at $7K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.